Uneventful administration of vincristine in Charcot-Marie-Tooth disease type 1X

Pediatric Blood and Cancer

Volumn 50, Issue 4, 2008, Pages 874-876

  Ajitsaria, Richa ^a   Reilly, Mary ^b   Anderson, John ^a,c,d  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Unit of Molecular Haematology and Cancer Biology   (United Kingdom)

Author keywords

Charcot Maire tooth; Connexin 32; Vincristine neuropathy

Indexed keywords

CONNEXIN 32; VINCRISTINE;

ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; COMORBIDITY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SAFETY; FAMILY HISTORY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; NEPHROBLASTOMA; NEUROPATHY; PERIPHERAL NEUROPATHY; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; X CHROMOSOME LINKED DISORDER;

ANTINEOPLASTIC AGENTS; CHARCOT-MARIE-TOOTH DISEASE; CHILD, PRESCHOOL; CONNEXINS; FEMALE; HUMANS; POINT MUTATION; VINCRISTINE; WILMS TUMOR;

EID: 40449122214     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21221     Document Type: Article

References (26)